Trade Elekta B - EKTAb CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
| Spread | 0.40 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.021246% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.000976% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | SEK | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | Sweden | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Elekta AB (publ) ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
| Prev. Close* | 74.1 |
| Open* | 74.75 |
| 1-Year Change* | 34.81% |
| Day's Range* | 74.2 - 75.3 |
| 52 wk Range | 53.24-90.42 |
| Average Volume (10 days) | 1.42M |
| Average Volume (3 months) | 24.50M |
| Market Cap | 27.49B |
| P/E Ratio | 25.47 |
| Shares Outstanding | 382.08M |
| Revenue | 17.37B |
| EPS | 2.93 |
| Dividend (Yield %) | 3.21802 |
| Beta | 0.99 |
| Next Earnings Date | Nov 30, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 25, 2023 | 74.10 | 1.15 | 1.58% | 72.95 | 74.45 | 72.55 |
| Sep 22, 2023 | 72.80 | -1.90 | -2.54% | 74.70 | 75.25 | 70.20 |
| Sep 21, 2023 | 75.10 | 0.35 | 0.47% | 74.75 | 76.00 | 74.35 |
| Sep 20, 2023 | 75.35 | 1.10 | 1.48% | 74.25 | 76.30 | 74.25 |
| Sep 19, 2023 | 74.65 | -0.70 | -0.93% | 75.35 | 75.85 | 74.00 |
| Sep 18, 2023 | 76.00 | 1.05 | 1.40% | 74.95 | 77.15 | 74.75 |
| Sep 15, 2023 | 75.25 | 0.00 | 0.00% | 75.25 | 76.65 | 75.25 |
| Sep 14, 2023 | 75.20 | 0.80 | 1.08% | 74.40 | 75.30 | 74.20 |
| Sep 13, 2023 | 74.50 | 0.60 | 0.81% | 73.90 | 74.85 | 73.50 |
| Sep 12, 2023 | 74.50 | -0.15 | -0.20% | 74.65 | 75.05 | 73.90 |
| Sep 11, 2023 | 74.50 | 0.40 | 0.54% | 74.10 | 75.30 | 74.10 |
| Sep 8, 2023 | 74.10 | -0.05 | -0.07% | 74.15 | 74.40 | 72.70 |
| Sep 7, 2023 | 74.20 | -0.95 | -1.26% | 75.15 | 75.55 | 73.90 |
| Sep 6, 2023 | 75.40 | -1.15 | -1.50% | 76.55 | 76.55 | 75.35 |
| Sep 5, 2023 | 77.00 | -1.15 | -1.47% | 78.15 | 78.50 | 76.85 |
| Sep 4, 2023 | 78.30 | 0.50 | 0.64% | 77.80 | 79.15 | 77.05 |
| Sep 1, 2023 | 77.55 | -0.65 | -0.83% | 78.20 | 78.30 | 77.00 |
| Aug 31, 2023 | 78.20 | -0.10 | -0.13% | 78.30 | 79.00 | 77.05 |
| Aug 30, 2023 | 78.30 | -0.20 | -0.25% | 78.50 | 79.30 | 77.75 |
| Aug 29, 2023 | 78.55 | 1.60 | 2.08% | 76.95 | 78.60 | 75.85 |
Elekta B Events
| Time (UTC) | Country | Event |
|---|---|---|
| Thursday, November 30, 2023 | ||
| Time (UTC) 10:59 | Country SE
| Event Q2 2024 Elekta AB (publ) Earnings Release Q2 2024 Elekta AB (publ) Earnings ReleaseForecast -Previous - |
| Thursday, February 22, 2024 | ||
| Time (UTC) 06:30 | Country SE
| Event Q3 2024 Elekta AB (publ) Earnings Release Q3 2024 Elekta AB (publ) Earnings ReleaseForecast -Previous - |
| Monday, February 26, 2024 | ||
| Time (UTC) 12:00 | Country SE
| Event Elekta AB (publ) Elekta AB (publ)Forecast -Previous - |
- Annual
- Quarterly
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Total revenue | 16869 | 14548 | 13763 | 14601 | 13555 |
| Revenue | 16869 | 14548 | 13763 | 14601 | 13555 |
| Cost of Revenue, Total | 10449 | 9111 | 8153 | 8464 | 7875 |
| Gross Profit | 6420 | 5437 | 5610 | 6137 | 5680 |
| Total Operating Expense | 15438 | 12905 | 11857 | 12944 | 11859 |
| Selling/General/Admin. Expenses, Total | 2381 | 2122 | 1842 | 2133 | 2138 |
| Research & Development | 374 | 840 | 765 | 871 | 892 |
| Depreciation / Amortization | 1423 | 938 | 1108 | 1190 | 897 |
| Interest Expense (Income) - Net Operating | 434 | -155 | -97 | 298 | 80 |
| Unusual Expense (Income) | 312 | -70 | |||
| Other Operating Expenses, Total | 65 | 49 | 86 | -12 | 47 |
| Operating Income | 1431 | 1643 | 1906 | 1657 | 1696 |
| Interest Income (Expense), Net Non-Operating | -150 | -88 | -215 | -151 | -86 |
| Other, Net | -83 | -54 | -61 | -52 | -30 |
| Net Income Before Taxes | 1198 | 1501 | 1630 | 1454 | 1580 |
| Net Income After Taxes | 944 | 1156 | 1253 | 1084 | 1198 |
| Minority Interest | -1 | -3 | 1 | 0 | 0 |
| Net Income Before Extra. Items | 943 | 1153 | 1254 | 1084 | 1198 |
| Net Income | 943 | 1153 | 1254 | 1084 | 1198 |
| Income Available to Common Excl. Extra. Items | 943 | 1154 | 1254 | 1084 | 1198 |
| Income Available to Common Incl. Extra. Items | 943 | 1154 | 1254 | 1084 | 1198 |
| Diluted Net Income | 943 | 1154 | 1254 | 1084 | 1198 |
| Diluted Weighted Average Shares | 382.367 | 382.083 | 382.083 | 382.062 | 382.027 |
| Diluted EPS Excluding Extraordinary Items | 2.46622 | 3.02029 | 3.28201 | 2.83724 | 3.1359 |
| Dividends per Share - Common Stock Primary Issue | 2.4 | 2.4 | 2.2 | 1.8 | 1.8 |
| Diluted Normalized EPS | 3.10919 | 3.02029 | 3.28201 | 2.83724 | 2.99697 |
| Total Adjustments to Net Income | 1 |
| Jul 2023 | Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | |
|---|---|---|---|---|---|
| Total revenue | 3828 | 5124 | 4337 | 4081 | 3327 |
| Revenue | 3828 | 5124 | 4337 | 4081 | 3327 |
| Cost of Revenue, Total | 2237 | 3187 | 2674 | 2557 | 2032 |
| Gross Profit | 1591 | 1937 | 1663 | 1524 | 1295 |
| Total Operating Expense | 3416 | 4340 | 4006 | 3882 | 3210 |
| Selling/General/Admin. Expenses, Total | 734 | 696 | 703 | 723 | 701 |
| Research & Development | 253 | 167 | 225 | 217 | 278 |
| Depreciation / Amortization | 133 | 124 | 126 | 113 | 112 |
| Interest Expense (Income) - Net Operating | 31 | 98 | 126 | 142 | 68 |
| Other Operating Expenses, Total | 13 | 19 | 19 | 13 | 5 |
| Operating Income | 412 | 784 | 331 | 199 | 117 |
| Interest Income (Expense), Net Non-Operating | -107 | -96 | -58 | -40 | -39 |
| Net Income Before Taxes | 305 | 688 | 273 | 160 | 78 |
| Net Income After Taxes | 238 | 546 | 216 | 122 | 60 |
| Minority Interest | 0 | -1 | 0 | 0 | 0 |
| Net Income Before Extra. Items | 238 | 545 | 216 | 122 | 60 |
| Net Income | 238 | 545 | 216 | 122 | 60 |
| Income Available to Common Excl. Extra. Items | 238 | 546 | 216 | 121 | 60 |
| Income Available to Common Incl. Extra. Items | 238 | 546 | 216 | 121 | 60 |
| Diluted Net Income | 238 | 546 | 216 | 121 | 60 |
| Diluted Weighted Average Shares | 382.596 | 383.468 | 382 | 382.083 | 382.083 |
| Diluted EPS Excluding Extraordinary Items | 0.62207 | 1.42385 | 0.56545 | 0.31669 | 0.15703 |
| Dividends per Share - Common Stock Primary Issue | 0 | 1.2 | 0 | 1.2 | 0 |
| Diluted Normalized EPS | 0.65266 | 1.52526 | 0.84092 | 0.55017 | 0.18522 |
| Total Adjustments to Net Income | 1 | -1 | |||
| Other, Net | 1 | ||||
| Unusual Expense (Income) | 15 | 49 | 133 | 117 | 14 |
- Annual
- Quarterly
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Total Current Assets | 14375 | 12880 | 13247 | 15566 | 12897 |
| Cash and Short Term Investments | 3278 | 3077 | 4411 | 6469 | 4118 |
| Cash & Equivalents | 3278 | 3074 | 3619 | 5166 | 2357 |
| Short Term Investments | 3 | 792 | 1303 | 1761 | |
| Total Receivables, Net | 8026 | 6350 | 5800 | 5597 | 5488 |
| Accounts Receivable - Trade, Net | 6109 | 5443 | 5053 | 4905 | 4856 |
| Total Inventory | 3070 | 2533 | 2283 | 2748 | 2634 |
| Prepaid Expenses | 793 | 534 | 654 | 585 | |
| Other Current Assets, Total | 1 | 127 | 219 | 98 | 72 |
| Total Assets | 29608 | 26303 | 24844 | 28411 | 24064 |
| Property/Plant/Equipment, Total - Net | 1753 | 1929 | 1850 | 2124 | 957 |
| Property/Plant/Equipment, Total - Gross | 3635 | 3329 | 3579 | 2254 | |
| Accumulated Depreciation, Total | -1705 | -1479 | -1455 | -1298 | |
| Goodwill, Net | 6499 | 5973 | 6302 | 5914 | |
| Intangibles, Net | 11722 | 3763 | 2806 | 3167 | 3387 |
| Long Term Investments | 1055 | 615 | 533 | 748 | 508 |
| Note Receivable - Long Term | |||||
| Other Long Term Assets, Total | 703 | 617 | 435 | 504 | 401 |
| Total Current Liabilities | 12706 | 11564 | 11941 | 11300 | 11897 |
| Accounts Payable | 1809 | 1352 | 1016 | 1025 | 1427 |
| Accrued Expenses | 1994 | 1901 | 1837 | 1703 | 1661 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | |
| Current Port. of LT Debt/Capital Leases | 250 | 755 | 2341 | 1214 | 1000 |
| Other Current Liabilities, Total | 8653 | 7556 | 6747 | 7358 | 7809 |
| Total Liabilities | 19879 | 17390 | 16647 | 20299 | 16286 |
| Total Long Term Debt | 6418 | 4940 | 3897 | 8144 | 3558 |
| Long Term Debt | 5706 | 4099 | 3043 | 7101 | 3558 |
| Deferred Income Tax | 549 | 515 | 545 | 587 | |
| Minority Interest | 4 | 3 | 0 | 1 | 1 |
| Other Liabilities, Total | 751 | 334 | 294 | 309 | 243 |
| Total Equity | 9729 | 8913 | 8197 | 8112 | 7778 |
| Common Stock | 192 | 192 | 192 | 192 | |
| Retained Earnings (Accumulated Deficit) | 6882 | 6568 | 5830 | 5555 | |
| Other Equity, Total | 9729 | 1839 | 1437 | 2090 | 2031 |
| Total Liabilities & Shareholders’ Equity | 29608 | 26303 | 24844 | 28411 | 24064 |
| Total Common Shares Outstanding | 382.083 | 382.083 | 382.083 | 383.568 | 382.027 |
| Capital Lease Obligations | 712 | 841 | 854 | 1043 |
| Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 14375 | 13246 | 12526 | 12394 | 12880 |
| Cash and Short Term Investments | 3278 | 1218 | 1535 | 2423 | 3077 |
| Cash & Equivalents | 3278 | 1218 | 1535 | 2423 | 3077 |
| Short Term Investments | |||||
| Total Receivables, Net | 8026 | 8691 | 7775 | 6982 | 7143 |
| Accounts Receivable - Trade, Net | 6109 | 6526 | 5713 | 5125 | 5443 |
| Total Inventory | 3070 | 3337 | 3216 | 2990 | 2533 |
| Other Current Assets, Total | 1 | -1 | 127 | ||
| Total Assets | 29608 | 27971 | 27225 | 26322 | 26303 |
| Property/Plant/Equipment, Total - Net | 1753 | 1794 | 1892 | 1907 | 1929 |
| Intangibles, Net | 11722 | 11492 | 11390 | 10666 | 10262 |
| Long Term Investments | 1055 | 726 | 720 | 719 | 615 |
| Other Long Term Assets, Total | 703 | 713 | 697 | 636 | 617 |
| Total Current Liabilities | 12706 | 12679 | 12318 | 11499 | 11564 |
| Accounts Payable | 1809 | 1390 | 1464 | 1280 | 1352 |
| Accrued Expenses | 1994 | 1937 | 1835 | 1606 | 1901 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | |
| Current Port. of LT Debt/Capital Leases | 250 | 758 | 787 | 780 | 755 |
| Other Current Liabilities, Total | 8653 | 8594 | 8232 | 7833 | 7556 |
| Total Liabilities | 19879 | 18347 | 18098 | 17243 | 17390 |
| Total Long Term Debt | 6418 | 4881 | 4922 | 4919 | 4940 |
| Long Term Debt | 5706 | 4152 | 4138 | 4112 | 4099 |
| Capital Lease Obligations | 712 | 729 | 784 | 807 | 841 |
| Deferred Income Tax | 487 | 503 | 483 | 549 | |
| Minority Interest | 4 | 4 | 4 | 3 | 3 |
| Other Liabilities, Total | 751 | 296 | 351 | 339 | 334 |
| Total Equity | 9729 | 9624 | 9127 | 9079 | 8913 |
| Other Equity, Total | 9729 | 9624 | 9127 | 9079 | 8913 |
| Total Liabilities & Shareholders’ Equity | 29608 | 27971 | 27225 | 26322 | 26303 |
| Total Common Shares Outstanding | 382.083 | 382.083 | 382.083 | 382.083 | 382.083 |
- Annual
- Quarterly
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 1198 | 1501 | 1630 | 1454 | 1580 |
| Cash From Operating Activities | 1964 | 1858 | 2551 | 1014 | 1621 |
| Cash From Operating Activities | 1062 | 1039 | 1204 | 1275 | 943 |
| Non-Cash Items | 299 | -105 | 511 | 204 | 112 |
| Cash Taxes Paid | 290 | 452 | 465 | 261 | 269 |
| Cash Interest Paid | 156 | 249 | 208 | 175 | |
| Changes in Working Capital | -595 | -577 | -794 | -1919 | -1014 |
| Cash From Investing Activities | -1615 | -1649 | -613 | -1298 | -674 |
| Capital Expenditures | -1564 | -1408 | -845 | -762 | -659 |
| Other Investing Cash Flow Items, Total | -51 | -241 | 232 | -536 | -15 |
| Cash From Financing Activities | -129 | -1726 | -3605 | 2624 | -1473 |
| Financing Cash Flow Items | 788 | 1 | 1 | 1 | 0 |
| Total Cash Dividends Paid | -917 | -841 | -688 | -688 | -535 |
| Issuance (Retirement) of Debt, Net | -886 | -2918 | 3311 | -938 | |
| Foreign Exchange Effects | -18 | 183 | -329 | -5 | 142 |
| Net Change in Cash | 202 | -1334 | -1996 | 2335 | -384 |
| Apr 2023 | Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 1198 | 510 | 237 | 78 | 1501 |
| Cash From Operating Activities | 1964 | -27 | -253 | -198 | 1858 |
| Cash From Operating Activities | 1062 | 803 | 528 | 262 | 1039 |
| Non-Cash Items | 299 | 187 | -45 | 61 | -105 |
| Cash Taxes Paid | 290 | 251 | 178 | 33 | 452 |
| Cash Interest Paid | 156 | ||||
| Changes in Working Capital | -595 | -1527 | -973 | -599 | -577 |
| Cash From Investing Activities | -1615 | -1184 | -760 | -394 | -1649 |
| Capital Expenditures | -1564 | -1146 | -758 | -395 | -1408 |
| Other Investing Cash Flow Items, Total | -51 | -38 | -2 | 1 | -241 |
| Cash From Financing Activities | -129 | -661 | -564 | -45 | -1726 |
| Financing Cash Flow Items | 788 | -202 | -105 | -45 | 1 |
| Total Cash Dividends Paid | -917 | -459 | -459 | -841 | |
| Issuance (Retirement) of Debt, Net | -886 | ||||
| Foreign Exchange Effects | -18 | 14 | 34 | -16 | 183 |
| Net Change in Cash | 202 | -1858 | -1543 | -653 | -1334 |
| Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
|---|---|---|---|---|---|---|
| Fjärde AP-Fonden | Pension Fund | 9.5502 | 35200795 | -50000 | 2023-05-31 | LOW |
| Leksell (Laurent & Family) | Other Insider Investor | 6.1688 | 22737393 | 0 | 2023-05-31 | MED |
| T. Rowe Price Associates, Inc. | Investment Advisor | 4.7707 | 17584257 | 211711 | 2023-05-31 | LOW |
| Nordea Funds Oy | Investment Advisor | 4.6385 | 17096854 | 370821 | 2023-05-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.4926 | 12873118 | 267178 | 2023-05-31 | LOW |
| SEB Investment Management AB | Investment Advisor | 3.3926 | 12504650 | -224398 | 2023-05-31 | LOW |
| Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 3.1913 | 11762641 | -4946589 | 2023-05-31 | LOW |
| Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 3.0588 | 11274349 | 0 | 2023-04-30 | LOW |
| Handelsbanken Kapitalförvaltning AB | Investment Advisor/Hedge Fund | 2.6536 | 9781011 | -373487 | 2023-05-31 | LOW |
| Didner & Gerge Fonder AB | Investment Advisor | 2.4739 | 9118503 | 300000 | 2023-05-31 | LOW |
| Swedbank Robur Fonder AB | Investment Advisor/Hedge Fund | 2.0723 | 7638165 | -1463589 | 2023-06-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.8999 | 7002847 | -638023 | 2022-12-31 | LOW |
| Tredje AP Fonden | Pension Fund | 1.4693 | 5415719 | 340000 | 2022-12-31 | MED |
| Carnegie Fonder AB | Bank and Trust | 1.4325 | 5280000 | 280000 | 2023-06-30 | LOW |
| Oddo BHF Asset Management S.A.S | Investment Advisor/Hedge Fund | 1.3899 | 5122978 | 0 | 2023-06-30 | LOW |
| Lannebo Fonder AB | Investment Advisor/Hedge Fund | 1.3864 | 5110000 | 350000 | 2023-06-30 | LOW |
| Allianz Global Investors GmbH | Investment Advisor | 1.237 | 4559414 | 0 | 2023-07-31 | LOW |
| Columbia Threadneedle Investments (UK) | Investment Advisor/Hedge Fund | 1.2199 | 4496467 | -2 | 2023-06-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.1816 | 4355084 | 14524 | 2023-07-31 | LOW |
| Indecap AB | Investment Advisor/Hedge Fund | 0.9697 | 3574305 | 178351 | 2023-07-31 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Elekta Company profile
About Elekta AB (publ)
Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. The Company has four product areas: Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases; Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization; Elekta Brachytherapy, which is engaged in the treatment of cancer through internal radiation, and Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology. The Company owns the service business of Asesores Electronicos Especializados SA de CV (AEESA).
Financial summary
BRIEF: For the nine months ended 31 January 2022, Elekta AB (publ) revenues increased 2% to SEK10.31B. Net income decreased 19% to SEK738M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Europe, Middle East and Africa segment income decrease of 63% to SEK481M, Asia Pacific segment income decrease of 66% to SEK402M.
Equity composition
10/2005, 3-for-1 stock split. 9/2012, 4-for-1 stock split (Factor: 4).
| Industry: | Advanced Medical Equipment & Technology (NEC) |
Kungstensgatan 18
STOCKHOLM
STOCKHOLM 113 57
SE
Income Statement
- Annual
- Quarterly
News
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023
Cable coils near lows ahead of Fed and BoE rate decisions
It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.
14:16, 19 September 2023
FTSE 100 Technical Outlook - 18 September 2023
In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.
06:55, 19 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com